Addex Therapeutics Ltd reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was CHF 0.630877 million compared to CHF 0.183354 million a year ago. Net loss was CHF 2.68 million compared to CHF 7.22 million a year ago. Basic loss per share from continuing operations was CHF 0.04 compared to CHF 0.19 a year ago.
For the six months, sales was CHF 1.13 million compared to CHF 0.420591 million a year ago. Net loss was CHF 5.08 million compared to CHF 13.04 million a year ago. Basic loss per share from continuing operations was CHF 0.08 compared to CHF 0.34 a year ago.